{"title":"25th silver anniversary of perspectives in vascular surgery and endovascular therapy.","authors":"Peter Gloviczki","doi":"10.1177/1531003514524125","DOIUrl":"https://doi.org/10.1177/1531003514524125","url":null,"abstract":"","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":" ","pages":"45"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003514524125","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40306822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Health care update: hospital employment or private practice?","authors":"Bhagwan Satiani","doi":"10.1177/1531003513510952","DOIUrl":"https://doi.org/10.1177/1531003513510952","url":null,"abstract":"<p><p>The increased operating cost of running a practice, decreasing reimbursement, and general pessimism is leading to increasing number of physicians choosing employment by hospitals and large physician groups. Although over 50% of members of the Society for Vascular Surgery are currently in a practice of less than 3 surgeons and over half of all private practitioners are employed by physician groups, the landscape is shifting quickly. Younger physicians finishing training are increasingly opting for employment. Hospitals are also anxious to hire vascular surgeons to maintain or increase market share of chronic disease management and preempt hiring difficulties with future shortages of vascular surgeons. New vascular surgeons have to carefully weigh the pros and cons of employment before making a decision. </p>","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"25 3-4","pages":"46-52"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003513510952","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31886886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SreyRam Kuy, Anahita Dua, Sapan S Desai, Henryk Baraniewski, Cheong J Lee
{"title":"Ruptured mycobacterial aneurysm of the carotid artery.","authors":"SreyRam Kuy, Anahita Dua, Sapan S Desai, Henryk Baraniewski, Cheong J Lee","doi":"10.1177/1531003513512870","DOIUrl":"https://doi.org/10.1177/1531003513512870","url":null,"abstract":"<p><p>Mycotic aneurysms resulting from intravesical bacillus Calmette-Guérin (BCG) treatment are exceptionally rare. We report on the case of a 73-year-old man who underwent intravesical therapy of BCG for bladder carcinoma and developed a right neck mass. A carotid pseudoaneurysm within a fibrotic mass was noted on surgical exploration. Radical resection was performed followed by a polytetrafluoroethylene interposition graft. Final pathology revealed necrotizing granulomas and multinucleated giant cells concerning for tuberculoma. Intravesicular BCG immunotherapy is an accepted treatment for patients with urothelial carcinoma. Carotid aneurysms are exceptionally rare in this setting and should prompt evaluation for systemic tuberculoid dissemination. </p>","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"25 3-4","pages":"53-6"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003513512870","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31960830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tiziano Tallarita, Maurizio Gerbino, Carmelina Gurrieri, Giuseppe Lanzino
{"title":"History of carotid surgery: from ancient greeks to the modern era.","authors":"Tiziano Tallarita, Maurizio Gerbino, Carmelina Gurrieri, Giuseppe Lanzino","doi":"10.1177/1531003513517010","DOIUrl":"https://doi.org/10.1177/1531003513517010","url":null,"abstract":"<p><p>A relationship between decreased carotid arterial flow and apoplectic manifestations was already suspected by the ancient Greeks. Early attempts at carotid surgery, however, were limited to emergency arterial ligation in patients with neck trauma. Attempts to suture arterial stumps together to restore blood flow paved the way for Carrel's revolutionary idea of reconstructing the resected or injured arterial segment with an interposition vein graft. DeBakey and Eastcott were the first to perform carotid endarterectomy in North America and the United Kingdom, respectively. In 1959, DeBakey proposed a cooperative study to assess the effectiveness of carotid endarterectomy in the treatment and prevention of ischemic cerebrovascular disease. The study was officially designated the Joint Study of Extracranial Arterial Occlusion and represented the first trial in the United States in which large numbers of patients were randomly allocated to surgical or nonsurgical therapy. </p>","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"25 3-4","pages":"57-64"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003513517010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31971339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Stent fracture in the superficial femoral and proximal popliteal arteries: literature summary and economic impacts.","authors":"Nancy Neil","doi":"10.1177/1531003513509122","DOIUrl":"https://doi.org/10.1177/1531003513509122","url":null,"abstract":"<p><strong>Objectives: </strong>To summarize available evidence regarding stent fracture in the femoropopliteal region.</p><p><strong>Methods: </strong>We searched PubMed, 2000-2011, using MeSH search terms \"stents,\" \"popliteal artery,\" and \"femoral artery.\"</p><p><strong>Results: </strong>We identified 29 original studies reporting 0% to 65% incidence of stent fracture. Fracture-related repeat revascularization could be avoided in the absence of device failure. Recently published data suggest that even a 5% rate of fracture-related reintervention would generate $118.4 million in health care cost in the United States. These excess procedures would also result in major complications and deaths that might have been avoided in the absence of stent fracture.</p><p><strong>Conclusions: </strong>Reported incidence and clinical relevance of femoropopliteal stent fractures vary across studies. Stent fracture may lead to repeat revascularization. These reinterventions create considerable--and potentially avoidable--economic burden for patients and payers. Further, these costs are effectively invisible wherever stent fractures are not systematically documented as the reason for reintervention.</p>","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"25 1-2","pages":"20-7"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003513509122","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31861104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gustavo S Oderich, Bernardo C Mendes, Karina S Kanamori
{"title":"Technique of implantation and bail-out maneuvers for endovascular fenestrated repair of juxtarenal aortic aneurysms.","authors":"Gustavo S Oderich, Bernardo C Mendes, Karina S Kanamori","doi":"10.1177/1531003513512372","DOIUrl":"https://doi.org/10.1177/1531003513512372","url":null,"abstract":"<p><p>Endovascular repair of complex aneurysms involving the visceral arteries has become a reality. Fenestrated endovascular aortic repair (FEVAR) has been used with increasing frequency to treat complex aortic aneurysms. The Zenith fenestrated stent-graft system (Cook Medical Inc, Brisbane, Australia) was approved for commercial use in the United States in April 2012, offering a custom-made design with up to 3 fenestrations to treat short-neck infrarenal and juxtarenal abdominal aortic aneurysms. Nevertheless, FEVAR is a complex procedure that demands accurate planning, advanced endovascular skills, and excellent perioperative patient care to achieve optimal outcomes. This article summarizes the basic concepts of device design, case planning, techniques of implantation, and some of the \"bail-out\" maneuvers that may be required during endovascular repair using the Zenith fenestrated stent-graft system. </p>","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"25 1-2","pages":"28-37"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003513512372","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31936899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michele Piazza, Peter Gloviczki, Ying Huang, Manju Kalra, Audra A Duncan, Gustavo S Oderich, William S Harmsen, Thomas C Bower
{"title":"Evolution in management and outcome after repair of abdominal aortic aneurysms in the pre- and post-EVAR era.","authors":"Michele Piazza, Peter Gloviczki, Ying Huang, Manju Kalra, Audra A Duncan, Gustavo S Oderich, William S Harmsen, Thomas C Bower","doi":"10.1177/1531003513506267","DOIUrl":"https://doi.org/10.1177/1531003513506267","url":null,"abstract":"<p><strong>Objective: </strong>To compare outcomes of abdominal aortic aneurysm repairs before and after the endovascular era.</p><p><strong>Methods: </strong>Group A (1997-1998) included 331 patients, 321 (97%) with open repair (OR) and 10 (3%) with endovascular aneurysm repair (EVAR). Group B (2007-2008) included 330 patients, 136 (41%) with OR and 194 (59%) with EVAR.</p><p><strong>Results: </strong>Patients in Group B were older (74 ± 8.5 vs 73 ± 7.0 years, P = .02), had higher comorbidity scores (8.3 ± 4.8 vs 7.5 ± 4.6, P = .04), shorter hospitalization (5.1 ± 6.4 vs 9.8 ± 6.3, P < .001), less intensive care unit days than in Group B (0.9 ± 2.1 vs 2.2 ± 2.7, P < .001). Early mortality was 0.6% in both groups. Two-year survival was similar (88% vs 89%), with less reinterventions in Group A (4% vs 17%, P = .004). OR patients had similar 30-day mortalities (0.9% vs 0.7%, P = .89).</p><p><strong>Conclusion: </strong>EVAR and OR have low mortalities. However, in the post-EVAR era we treat older patients with more comorbidities, hospitalization is shorter, and intensive care unit days are less; interventions in EVAR are, however, high.</p>","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"25 1-2","pages":"11-9"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003513506267","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31861102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anahita Dua, Bhavin Patel, Jennifer Heller, SreyRam Kuy, Joseph DuBose, Jeffrey S Tomasek, Eric Mowatt Larssen, Sapan S Desai
{"title":"Variability in the management of superficial venous thrombophlebitis among phlebologists and vascular surgeons.","authors":"Anahita Dua, Bhavin Patel, Jennifer Heller, SreyRam Kuy, Joseph DuBose, Jeffrey S Tomasek, Eric Mowatt Larssen, Sapan S Desai","doi":"10.1177/1531003513506266","DOIUrl":"https://doi.org/10.1177/1531003513506266","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to compare management patterns of patients with superficial venous thrombophlebitis (SVT) among phlebologists and vascular surgeons.</p><p><strong>Methods: </strong>A survey was provided to practitioners who attended the American Venous Forum meeting in 2011. Statistical analysis included descriptive statistics, unpaired t tests, and Friedman's test for correlation.</p><p><strong>Results: </strong>There were 354 US or Canadian health care providers of whom 169 were phlebologists and 185 were vascular surgeons. There was a significant different in anticoagulation administration and duration (P = .034, P = .032, respectively). Friedman's test for correlation between multiple surgical treatments showed no correlation between surgical treatments tested with all treatments having an equal distribution in our data. Follow-up differed between groups with vascular surgeons following up with imaging more than phlebologists (P = .03).</p><p><strong>Conclusion: </strong>Our data indicate that there is no consensus between or among phlebologists or vascular surgeons as to the surgical management of superficial venous thrombophlebitis, duration of follow-up, and anticoagulation parameters.</p>","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"25 1-2","pages":"5-10"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003513506266","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31861103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The role of endografts in the management of type B aortic dissections.","authors":"Sira M Duson, Robert S Crawford","doi":"10.1177/1531003513491983","DOIUrl":"https://doi.org/10.1177/1531003513491983","url":null,"abstract":"<p><p>Type B aortic dissection is a rare, but deadly, disease process. Advances in endovascular therapy have provided alternative means for the management of aortic dissection. This comprehensive review examines the incidence, pathophysiology, presentation, diagnosis, risk factors, and management of type B aortic dissection, with an emphasis on endovascular intervention. Additionally, this review provides current information regarding the procedural outcomes, complications, mortality, and overall survival of endovascular versus conventional management of type B aortic dissections. </p>","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"24 4","pages":"177-83"},"PeriodicalIF":0.0,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003513491983","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31537139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Celal Cinar, Halil Bozkaya, Mustafa Parildar, İsmail Oran
{"title":"A rare cause of obstructive jaundice: superior mesenteric artery pseudoaneurysm.","authors":"Celal Cinar, Halil Bozkaya, Mustafa Parildar, İsmail Oran","doi":"10.1177/1531003513491987","DOIUrl":"https://doi.org/10.1177/1531003513491987","url":null,"abstract":"<p><p>Visceral arterial aneurysm and pseudoaneurysm are uncommon forms of vascular disease that have a significant potential for rupture or erosion into an adjacent viscera, resulting in life-threatening hemorrhage. Pseudoaneurysms related to the superior mesenteric artery are a recognized complication of trauma to the vessel, and successful treatment with stenting has been previously described. Percutaneous techniques offer an alternative form of therapy, and the number of reported cases treated with embolization has been rising steadily. We present the case of a 26-year-old patient with a large pseudoaneurysm of the superior mesenteric artery complicated with obstructive jaundice. </p>","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"24 4","pages":"212-6"},"PeriodicalIF":0.0,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003513491987","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31612577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}